妊娠期脑动静脉畸形首次出血风险的系统综述
该系统综述检索了MEDLINE、EMBASE和Scopus截至2018年4月的文献,评估妊娠期及产褥期脑动静脉畸形首次颅内出血的风险和年化率。最终纳入3项符合标准的研究,提取4个队列共47例妊娠期bAVM出血事件,各队列年化风险分别为3.0%、3.5%、8.6%和30%,仅最后一个队列较非妊娠期显著升高(相对率6.8,95%CI:3.6-13)。结论认为尚无确凿证据表明妊娠期bAVM首次出血风险增加,需开展回顾性多中心病例交叉研究。
要点
- 妊娠期bAVM首次出血年化风险各队列差异大,仅一个队列显著高于非妊娠期。
- 现有证据有限且方法异质,不能确认妊娠增加bAVM首次出血风险。
- 建议开展回顾性多中心病例交叉研究以明确妊娠期bAVM出血风险。
核心结论
- 尚无确凿证据表明妊娠期脑动静脉畸形首次出血风险增加。
- 因研究数量有限和结果变异大,亟需更严谨的回顾性多中心病例交叉研究。
研究设计与样本
- 系统综述检索MEDLINE、EMBASE和Scopus截至2018年4月的英文文献。
- 从7项初筛合格研究中纳入3项提供妊娠期bAVM首次出血定量风险的研究。
- 提取4个队列共47例妊娠期bAVM出血事件进行分析。
主要发现
- 4个队列妊娠期首次出血年化风险分别为3.0%(95%CI:1.7-5.2%)、3.5%(95%CI:2.4-4.5%)、8.6%(95%CI:1.8-25%)和30%(95%CI:18-49%)。
- 仅最后一个队列较非妊娠期显著升高(相对率6.8,95%CI:3.6-13)。
- 因方法和暴露期定义差异,未合并各队列病例。
临床怎么用
- 当前证据不足以支持妊娠期bAVM首次出血风险增高的确定性结论。
- 对bAVM女性妊娠管理建议应结合个体情况并告知证据局限性。
局限性
- 符合标准的研究数量有限。
- 各研究方法学和暴露期定义存在差异,结果变异大,未进行合并分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recommendations on the management of brain arteriovenous malformations (bAVM) with respect to pregnancy are based upon conflicting literature. OBJECTIVE: To systematically review the reported risk and annualized rate of first intracranial hemorrhage (ICH) from bAVM during pregnancy and puerperium. METHODS: MEDLINE, EMBASE, and Scopus databases were searched for relevant articles in English published before April 2018. Studies providing a quantitative risk of ICH in bAVM during pregnancy were eligible. RESULTS: From 7 initially eligible studies, 3 studies met the criteria for providing quantitative risk of first ICH bAVM during pregnancy. Data from 47 bAVM ICH during pregnancy across 4 cohorts were extracted for analysis. Due to differences in methodology and definitions of exposure period, it was not appropriate to combine the cases. The annualized risk of first ICH during pregnancy for these 4 cohorts was 3.0% (95% confidence interval [CI]: 1.7-5.2%); 3.5% (95% CI: 2.4-4.5%); 8.6% (95% CI: 1.8-25%); and 30% (95% CI: 18-49%). Only the last result from the last cohort could be considered significantly increased in comparison with the nonpregnant period (relative rate 6.8, 95% CI: 3.6-13). The limited number of eligible studies and variability in results highlighted the need for enhanced rigor of future research. CONCLUSION: There is no conclusive evidence of an increased risk of first hemorrhage during pregnancy from bAVM. Because advice to women with bAVM may influence the management of pregnancy or bAVM with significant consequences, we believe that a retrospective multicenter, case crossover study is urgently required.
引用
- Davidoff CL, Lo Presti A, Rogers JM, et al. Risk of First Hemorrhage of Brain Arteriovenous Malformations During Pregnancy: A Systematic Review of the Literature. Neurosurgery. 2019. PMID: 31149721. doi:10.1093/neuros/nyz175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。